SITE001-0068

SITE001 (USA) › SITE001-0068

SITE001-0068

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE001 (USA) · Dr. Reyes
consented 2025-11-16

enrolled

AEs

5

Serious

1

Dropout signal

+0.0

Luna — Sam Whitaker

Consent

pending

Messages

0

Escalations

0 escalations

Mood (avg feeling)

ø –

Meds adherence (7d)

–

Adverse events

5

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-01-23 (study day 241); relationship: RELATED

moderate assessed

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-12-22 (study day 209); relationship: NOT RELATED

moderate assessed

Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-10-19 (study day 145); relationship: not assessed

moderate assessed

Grade 4 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-10-03 (study day 129); relationship: NOT RELATED; serious criteria: life-threatening

severe serious assessed

Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-09-29 (study day 125); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.